5.0
29 Dec 2024
Current employee, less than 1 year
San Francisco, CA
Recommend
CEO approval
Business outlook
Pros
People seem to care about the work they are doing and believe they creating medicines to improve lives.
Cons
There is a lot of noise about Roche showing their rank, privilege and ownership over Genentech. Its felt and uncomfortable.